Amgen buys Horizon Therapeutics for US$ 25 billion
The US biotech company Amgen reached an agreement to buy Horizon Therapeutics for more than 25 billion dollars. Horizon holds ...
Read moreS&P 500 (USA)
4.076.60 58.83 1.46% 
NASDAQ Composite (USA)
11.584.55 190.74 1.67%
Dow Jones (USA)
34.086.04 368.95 1.09%
FTSE 100 (United Kingdom)
7.771.70 13.17 0.17% 
EURO STOXX 50 (Europe)
4.163,45 4,82 0,00%
Nikkei 225
27.346.88 19.77 0.07%
VIX
19.40 0.54 2.71%
Bitcoin (USD)
23.106.93 302.42 1.33%
Ethereum (USD)
1.580.25 14.66 0.94%
Tag: Horizon
Last published articles
INVESTOR TIMES is an independent publication of economic, finance and investment content, owned and operated by Altas Ventures.
Investing in Bitcoin